API's
Active Pharmaceutical Ingredients
Active Pharmaceutical Ingredients
Fluconazole Pellets are a specialized oral solid dosage form designed to deliver Fluconazole, a triazole antifungal agent. The pelletized formulation ensures improved drug stability, bioavailability, and controlled drug release, making it suitable for the development of modified-release capsules or sachets.
| Component | Function |
|---|---|
| Fluconazole | Active Pharmaceutical Ingredient (API) |
| Sugar Spheres / MCC Spheres | Inert core or starter pellets |
| Hydroxypropyl Methylcellulose (HPMC) | Binder / Film former during layering |
| Talc / Colloidal Silicon Dioxide | Anti-adherent / Glidant |
| Eudragit L30D-55 / Eudragit RS / HPMC-AS | Functional polymer coating (for controlled / delayed release) |
| Triethyl Citrate / PEG 6000 | Plasticizer (for coating flexibility) |
| Purified Water | Solvent (removed after processing) |
Outsourcing pellets through a trusted partner like Salius Pharma can be a strategic decision to save both time and resources, without compromising on quality or compliance. Instead, partnering with Salius Pharma—a leading distributor aligned with USFDA-approved and WHO-GMP-certified manufacturers in India—allows you to leverage high-quality products, seamless logistics, and professional support under one roof.
We ensure prompt and reliable shipping worldwide. Delivery times may vary depending on destination, order volume, and regulatory requirements.
Looking to source Fluconazole Pellets or other high-quality pharmaceutical pellet formulations?
Whether you need Active Pharmaceutical Ingredients (APIs), excipients, or regulatory support, our team is ready to provide reliable, compliant, and cost-effective solutions tailored to your market needs.
The contents of this page and any attachments are intended solely for the designated recipient(s) and may contain confidential and/or privileged information protected by law.
Any patented products are excluded from our offerings in regions where such patents are currently in force.
Fluconazole Pellets are primarily used in the treatment and prevention of fungal infections, including candidiasis, cryptococcal meningitis, and superficial mycoses. They are formulated for capsule filling or suspension dosage forms.
Pellets provide uniform drug release, reduced dose dumping risk, improved bioavailability, flexibility in dosage strength adjustment, and patient-friendly formulations.
Yes. They can be combined with other APIs in capsule dosage forms, especially for treating mixed fungal infections or prophylactic therapies in immunocompromised patients.
Quality is verified through validated HPLC methods in compliance with pharmacopeial standards (USP/BP/EP).